Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821825-25-000023
Filing Date
2025-05-02
Accepted
2025-05-02 08:42:12
Documents
87
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ogn-20250331.htm   iXBRL 10-Q 1205756
2 EX-31.1 ogn03312025-exhibit311.htm EX-31.1 8968
3 EX-31.2 ogn03312025-exhibit312.htm EX-31.2 9117
4 EX-32.1 ogn03312025-exhibit321.htm EX-32.1 6703
5 EX-32.2 ogn03312025-exhibit322.htm EX-32.2 6489
  Complete submission text file 0001821825-25-000023.txt   7757020

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogn-20250331.xsd EX-101.SCH 56969
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogn-20250331_cal.xml EX-101.CAL 58195
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogn-20250331_def.xml EX-101.DEF 272053
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogn-20250331_lab.xml EX-101.LAB 697400
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogn-20250331_pre.xml EX-101.PRE 486257
89 EXTRACTED XBRL INSTANCE DOCUMENT ogn-20250331_htm.xml XML 1274212
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40235 | Film No.: 25905623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)